Jenburkt Pharmaceuticals lost 1.21% to Rs 539 at 15:28 IST on BSE on profit booking after gaining 16.48% in the preceding seven trading sessions to settle at Rs 545.60 yesterday, 12 December 2017, from its close of Rs 468.40 on 1 December 2017.
Meanwhile, the S&P BSE Sensex was down 174.95 points, or 0.53% to 33,053.04. The S&P BSE Small-Cap index was down 146.07 points, or 0.81% to 17,981.85.
On the BSE, 5,651 shares were traded in the counter so far, compared with average daily volumes of 8,391 shares in the past one quarter. The stock had hit a high of Rs 553.45 and a low of Rs 539 so far during the day. The stock hit a record high of Rs 587.55 on 6 December 2017. The stock hit a 52-week low of Rs 388.90 on 1 February 2017.
The small-cap company has equity capital of Rs 4.65 crore. Face value per share is Rs 10.
Jenburkt Pharmaceuticals' net profit rose 97% to Rs 9.97 crore on 28.5% increase in total income to Rs 37.69 crore in Q2 September 2017 over Q2 September 2016.
Jenburkt Pharmaceuticals is engaged in the manufacture of pharmaceutical formulations. The company offers prescription and over-the-counter drugs.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content